Increased translocation of bacteria/bacterial products is observed in IAP−/− mice along with increased obesity [19] emphasizing the role of IAP not only in maintaining the intestinal barrier function but also in metabolic diseases. This evidence concerns the gene ALPI and metabolic disease.